期刊文献+

B-型钠尿肽系列测定判定急性冠脉综合征患者预后的价值 被引量:13

Prognostic value of serial BNP measurements in patients with acute coronary syndromes
下载PDF
导出
摘要 目的探索对急性冠脉综合征(ACS)患者,B-型钠尿肽(BNP)系列测定联合TnT、CRP与不良心脏事件发生率的关系。方法对83例ACS患者分别在入院时、48h、72h测定其BNP、TnT、CRP值,以死亡、心肌梗死、症状性心衰为随访终点,平均随访12个月,对BNP等生化指标与心脏事件发生率的相关性进行统计学分析。结果随访中发现,BNP>250ng/L的患者与BNP≤250ng/L的患者相比,心脏事件的发生率显著升高,为9%和27%(OR3.7,95%CI:2.3~5.7,P<0.01)。在TnT阴性的患者,高BNP组与低BNP组相比,其危险比为5.9(95%CI2.6~13.3,P<0.01)。在临床稳定、没有难治性心肌缺血的患者,BNP值快速下降,基线、48h、72h时的BNP值分别为248.6±10、188.9±8(-24%)、126.8±11(-49%),与基线相比,48h、72h差异均有统计学意义(P<0.01)。BNP在基线时水平较低,而在72h显著升高的患者,预后较差,OR值为24.0(95%CI:8.4~32.5,P<0.01)。而在基线时BNP值较高,72h时明显下降者,MACE发生率显著降低,与持续升高者相比,为16%vs38%(OR18.5,95%CI:7.6~21.3,P<0.01)。结论对ACS患者,BNP是一个强有力的预后判断指标,并且BNP的系列测定与单一基线水平测定相比,其预后判断价值显著增加。 Objective To evaluate the relationship between serial BNP measurements and cardiovascular events in patients with acute coronary syndromes(ACS). Methods BNP, troponin T(TnT) and C-reactive protein (CRP) were measured at baseline and at 48 and 72 hours in 83 patients with ACS. Death and myocardial infarction were recorded during 12 months of follow-up. Statistical analysis was done. Results For the later follow-up, baseline BNP levels higher were associated with higher event rates, event rates were significantly higher in patients with BNP〉250 ng/L than the patients with BNP≤250 ng/L (9% vs 27%,OR 3.7,95%CI:2.3-5.7,P〈 0.01). In troponin T negative patients,BNP identified a subgroup of high-risk patients (OR,5.9,95% CI, 2.6 to 13.3,P〈0.01 ). Importantly,clinical stabilization without refractory ischemia was associated with a rapid and significant (48 hours,-24%,72 hours , -49% , both P〈0.001 ) decline in BNP levels. In patients with high BNP baseline levels, lack of a rapid decline in BNP levels was linked to an adverse short-term prognosis(OR 18.5,95% CI:7.6 to 21.3 ,P〈0.01 ). In patients with low BNP baseline levels, a rise in BNP levels over 72 hours was also linked to an adverse prognosis (OR 24.0,95% CI:8.4 to 32.5,P〈0.01). Condusion BNP is a powerful and independent determinant of the short-term cardiac risk in patients with ACS, and serial BNP measurements are superior to a single BNP value obtained at baseline.
出处 《中国心血管病研究》 CAS 2008年第4期261-263,共3页 Chinese Journal of Cardiovascular Research
关键词 B-型钠尿肽 系列测定 急性冠脉综合征 预后 B-type natriuretic peptide (BNP) Serial measurements Acute coronary syndromes(ACS) Prognosis
  • 相关文献

参考文献10

  • 1[1]Hamm CW,Braunwald E.A classification of unstable angina revisited.Circulation,2000,102:1 18-122.
  • 2[2]Newby LK,Ohman EM,Christeuson RH,et al.Benefit of glycoproteinⅡb/Ⅲa inhibition in patients with acute coronary syndromes and tmponin T-positive status:the paragon-B troponin T substudy.Cireulation,2001,103:2891-2896.
  • 3[3]Harem CW,Bertrand M,Bmunwald E.Acute coronary syndrome without ST elevation:implementation of new guidelines.Lancet,2001,358:1533-1538.
  • 4[4]Sabatine MS,Morrow DA,de Lemos JA,et al.Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes:simultaneous assessment of troponin I,C-reactive protein,and B-type natriuretic peptide.Circulation,2002,105:1760-1763.
  • 5[5]Morrow DA,de Lemos JA.Sabatine MS,et al.Evaluation of B-type natriuretic paptide for risk assessment in unstable angina non-ST-elevation myocardial infarction:B-type natriuretic peptide and prognosis in TACTICS-TM1 18.J Am Coll Cardiol,2002,41:1264-1272.
  • 6[6]Jemberg T,Lindahl B,Siegbahn A,et al.N-terminal pro-brain natriuretic paptide in relation to inflammation,myocardial necrosis.and the effect of an invasive strategy in unstable coronary artery disease.J Am Coll Cardiol,2003,42:1909-1916.
  • 7[7]Omland T,de Lemos JA,Morrow DA,et al.Prognostic value of N-terminal pro-atrial and pro-brain natrituretic peptide in patients with acute coronary syndromes.Am J Cardiol,2002,89:463-465.
  • 8[8]De Lemos JA,Morrow DA,Bentley JH,et al.The prognostic value of B-type natrluretic peptide in patients with acute coronary syndremes.N Engl J Med,2001,345:1014-1021.
  • 9[9]Bibbins-Domingo K,Ansari M,Schiller NB,et al.B-type natriuretic peptide and isehemia in patients with stable coronary disease:data from the Heart and Soul Study.Circulation,2003,108:2987-2992.
  • 10[10]Jemberg T,Stridsberg M,Venge P,et al.N-terminal pro-brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation.J Am Coll Cardiol,2002,40:437-445.

同被引文献104

引证文献13

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部